Hansen Gwenn
Nurix Therapeutics, Inc. · Chief Scientific Officer
Hansen Gwenn is listed in public filings as officer: Chief Scientific Officer. This Hansen Gwenn insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nurix Therapeutics, Inc. (NRIX). Investors use Hansen Gwenn's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $70k3.4k shares | SellJul 30, 2024 | $20.67 | $17.47 | |
| $84k3.4k shares | SellOct 30, 2024 | $24.31 | $17.47 | |
| $6.8k333 shares | SellJan 30, 2025 | $20.33 | $17.47 | |
| $66k3.4k shares | SellJan 30, 2025 | $19.81 | $17.47 | |
| $39k3.4k shares | SellApr 30, 2025 | $11.50 | $17.47 | |
| $52k4.3k shares | SellJul 30, 2025 | $12.01 | $17.47 | |
| $52k4.1k shares | SellOct 30, 2025 | $12.80 | $17.47 | |
| $1.7k98 shares | SellJan 30, 2026 | $17.37 | $17.47 | |
| $80k4.8k shares | SellJan 30, 2026 | $16.58 | $17.47 | |
| $53k3.2k shares | SellApr 30, 2026 | $16.65 | $17.47 |